Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Mar 15, 2007 (Vol. 27, No. 6)

GeneBee

URL:www.genebee.msu.su
  • Analyses abound
  • Very clunky
ponsored by the Russian Foundation for Basic Research, GeneBee is a site that takes an unusual approach to serving molecular biology. Literally ‘abuzz’ (get it?) with search engines, GeneBee provides access to numerous tools for aligning and screening nucleic acid sequences. At GeneBee, one can search protein/nucleic acid databanks for keywords, perform multiple protein sequence alignments, format alignments visually, compare alignments, predict phylogenetic trees, do RNA secondary structure prediction, identify ORFs, BLAST, and use several other approaches to align desired sequences. While the site is literally a sequence analysis toolbox in a bottle, it does have its shortcomings; the chief of which is a set of clunky interfaces and the requirement for many of the routines to e-mail results back. Still, the analyses are free, so one shouldn’t be too snotty.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »